Influence of circulating epinephrine and norepinephrine on insulin-like growth factor binding protein-1 in humans

被引:22
作者
FernqvistForbes, E [1 ]
Hilding, A [1 ]
Ekberg, K [1 ]
Brismar, K [1 ]
机构
[1] KAROLINSKA HOSP, DEPT MOL MED, ENDOCRINE & DIABET UNIT, S-17176 STOCKHOLM, SWEDEN
关键词
D O I
10.1210/jc.82.8.2677
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to investigate the influence of circulating epinephrine (Epi) and norepinephrine (Norepi) on serum insulin-like growth factor binding protein-1 (IGFBP-1) concentrations. Healthy men received 0.3 nmol(.)kg(.)min Epi iv (n = 6), 0.5 nmol(.)kg(.)min Norepi iv (n = 7), or saline (n = 5) during 30 min. Arterial blood samples were obtained before, during, and 120 min after infusion. During the catecholamine infusion arterial Epi and Norepi plasma concentrations reached 6.35 +/- 0.53 and 15.65 +/- 2.71 nmol/L, respectively, which resulted in significant increases in glucose concentrations. When Epi was infused, IGFBP-1 increased from 45 +/- 6 mu g/L to 76 +/- 10 mu g/L (P < 0.05) 60 min after the infusion. Epi was also followed by increases in insulin, C-peptide, and glucagon. Norepi resulted in a slight increase in circulating IGFBP-1 (43 +/- 6 to 54 +/- 8 nmol/L, NS). The findings suggest that Epi, at plasma concentrations similar to those reached during physical stress, stimulates the production of IGFBP-1 in humans.
引用
收藏
页码:2677 / 2680
页数:4
相关论文
共 39 条
  • [1] BETA-ADRENOCEPTOR SUBTYPE EXPRESSION IN HUMAN LIVER
    ARNER, P
    ENGFELDT, P
    HELLSTROM, L
    LONNQVIST, F
    WAHRENBERG, H
    SONNENFELD, T
    BRONNEGARD, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (05) : 1119 - 1126
  • [2] BABAJKO S, 1995, GROWTH REGULAT, V5, P85
  • [3] BANAUCH D, 1975, Z KLIN CHEM KLIN BIO, V13, P101
  • [4] INSULIN DIFFERENTIALLY ALTERS TRANSCAPILLARY MOVEMENT OF INTRAVASCULAR IGFBP-1, IGFBP-2 AND ENDOTHELIAL-CELL IGF-BINDING PROTEINS IN THE RAT-HEART
    BAR, RS
    BOES, M
    CLEMMONS, DR
    BUSBY, WH
    SANDRA, A
    DAKE, BL
    BOOTH, BA
    [J]. ENDOCRINOLOGY, 1990, 127 (01) : 497 - 499
  • [5] BAXTER RC, 1991, ACTA PAEDIATR SCAND, P107
  • [6] EFFECT OF INSULIN ON THE HEPATIC PRODUCTION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 (IGFBP-1), IGFBP-3, AND IGF-I IN INSULIN-DEPENDENT DIABETES
    BRISMAR, K
    FERNQVISTFORBES, E
    WAHREN, J
    HALL, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) : 872 - 878
  • [7] INSULIN REGULATES THE 35-KDA IGF BINDING-PROTEIN IN PATIENTS WITH DIABETES-MELLITUS
    BRISMAR, K
    GUTNIAK, M
    POVOA, G
    WERNER, S
    HALL, K
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (08) : 599 - 602
  • [8] SUPPRESSION OF ENDOGENOUS INSULIN-SECRETION REGULATES THE RAPID RISE OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN (IGFBP)-1 LEVELS FOLLOWING ACUTE HYPOGLYCEMIA
    COTTERILL, AM
    HOLLY, JMP
    AMIEL, S
    WASS, JAH
    [J]. CLINICAL ENDOCRINOLOGY, 1993, 38 (06) : 633 - 639
  • [9] REGULATION OF THE GROWTH HORMONE-INDEPENDENT GROWTH FACTOR-BINDING PROTEIN IN CHILDREN
    COTTERILL, AM
    COWELL, CT
    BAXTER, RC
    MCNEIL, D
    SILINIK, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (05) : 882 - 887
  • [10] CRYER PE, 1980, NEW ENGL J MED, V303, P436